EUVIMEDEUVIMED entdecken
Open Access

Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease

Kanchana Soman Pillai iD, Parvathy Rajeswari, Ravindra B Kamble, Shagos Gopalan Nair Santhamma, Manas Chacko iD, Vijay Jayakrishnan, Ranjini Ramachandran, Ayana Avarachan, Asha Kishore iD

Movement Disorders Clinical Practice · 2025

DOI: 10.1002/mdc3.14346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Kanchana Soman Pillai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson and Movement Disorders Centre, Department of Neurology, Aster Medcity, Kochi, Kerala, India. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Parkinson Disease, Brain, Multimodal Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Aster Medcity Intramural research fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The new classification of progressive supranuclear palsy (PSP) subtypes necessitates identifying radiological biomarkers to support the clinical diagnosis.

Objective

The goal was to test if magnetic resonance imaging (MRI) morphometry, diffusion tensor imaging (DTI), susceptibility‐weighted imaging (SWI), or [18F]fluorodeoxyglucose ( 18F FDG)‐positron emission tomography (PET) differentiates PSP subtypes from each other or Parkinson's disease (PD).

Methods

Midbrain/pons (M/P) area ratio, middle/superior cerebellar peduncle (MCP/SCP) width ratio, magnetic resonance parkinsonism indices (MRPI and MRPI2) and midbrain antero‐posterior (AP) diameter were measured. Region of interest‐based DTI, SWI, and 18F FDG‐PET analyses were performed.

Results

Four PSP subtypes (n = 85) and 24 PD were studied. MRI morphometry and DTI could differentiate PSP‐Richardson syndrome (PSP‐RS) from PSP‐parkinsonism, PSP‐postural instability, and PD (area under curve >0.7). SWI did not differentiate among PSP subtypes or PD. 18F FDG‐PET distinguished PSP from PD.

Conclusions

MRI morphometry and DTI differentiated PSP‐RS from the other common PSP subtypes and PD and may be tested as a radiological marker of PSP‐RS in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveParkinson DiseaseBrainMultimodal ImagingHumansMaleFemaleAgedMagnetic Resonance ImagingPositron-Emission TomographyMiddle AgedDiffusion Tensor ImagingFluorodeoxyglucose F18Aged, 80 and over

Stichwörter der Autor:innen

DTIFDG‐PETMRISWIprogressive supranuclear palsy subtypes

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Parkinson and Movement Disorders Centre, Department of Neurology, Aster Medcity, Kochi, Kerala, India.
  • Department of Radiology, Aster CMI Hospital, Bengaluru, Karnataka, India.
  • Department of Nuclear Medicine, Aster Medcity, Kochi, Kerala, India.
  • Department of Radiology, Aster Medcity, Kochi, Kerala, India.

ORCID-Profile: Kanchana Soman Pillai, Manas Chacko, Asha Kishore

Förderung

  • Aster Medcity Intramural research fund

Zitieren

APA

Pillai, K. S., Rajeswari, P., Kamble, R. B., Gopalan Nair Santhamma, S., Chacko, M., Jayakrishnan, V., Ramachandran, R., Avarachan, A., & Kishore, A. (2025). Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14346

Vancouver

Pillai KS, Rajeswari P, Kamble RB, Gopalan Nair Santhamma S, Chacko M, Jayakrishnan V, et al. Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.14346

BibTeX
@article{Pillai2025,
  author = {Pillai, Kanchana Soman and Rajeswari, Parvathy and Kamble, Ravindra B and Gopalan Nair Santhamma, Shagos and Chacko, Manas and Jayakrishnan, Vijay and Ramachandran, Ranjini and Avarachan, Ayana and Kishore, Asha},
  title = {Multimodality Brain Imaging Markers in Progressive Supranuclear Palsy Subtypes and Parkinson's Disease},
  journal = {Movement Disorders Clinical Practice},
  year = {2025},
  doi = {10.1002/mdc3.14346}
}
Kostenlos starten →